Etiological factors and treatment of chylothorax in paediatric patients - a systematic review
DOI:
https://doi.org/10.12775/JEHS.2022.12.06.021Keywords
chylothorax, thoracic duct ligation, low fat diet, paediatricsAbstract
Chylothorax is an accumulation of chyle in the pleural cavity. It is a relatively rare cause of pleural effusion in children and its annual incidence is 14 cases per 100 000 children in Europe.
The pleural fluid triglyceride level greater than 110 mg/dl with a cholesterol level lower than 200 mg/dl confirms the diagnosis of chylothorax. Medical imaging are also necessary such as a non-invasive and easily accessible lung ultrasound. Symptoms of this disease are tachypnea, dyspnea, and in some cases dry cough.
This review aims to summarize the current literature regarding chylothorax in children, analyze its possible etiologies and treatments.
The causes of chylothorax are varied. It may appear after surgical interventions, traumas, infections and also be congenital. Iatrogenic factors are the most common cause of chylothorax in children with cardiothoracic surgeries. Management of chylothorax can be quite complex and highly variable, depending on patient’s condition and their response to the introduced treatment. Conservative treatment consisting of nutrition therapy, chest drain, and pharmacotherapy is typically a first-line of treatment. Diet modification consist in dietary supplements enriched with medium chain triglycerides (MCT) or starting the patient on a total parenteral nutrition (TPN). In most of the analyzed cases the conservative treatment alone proved sufficient in the management of chylothorax. In case of its failure, surgical treatment was a secondary therapy choice. One of the most common surgical procedures for pleural effusion is a thoracic duct ligation (TDL) or pleurodesis and both of these methods are highly effective therapy for chylothorax.
This review of the literature reveals a wide variety of causes and methods of treatment of chylothorax. There are no clear standards of management and the therapy is adjusted to the clinical condition of the patient.
References
Efrati O., Barak A.: “Pleural effusions in the pediatric population”. Pediatr Rev. 2002; 23 (12): 417-426.
Lin C., Lin W., Chang J.: “Presentations and management of different causes of chylothorax in children: one medical center's experience”. Biomedicine (Taipei). 2017; 7(1): 5.
Hermon M., Tenner E., Burda G. et al.: “Chylothorax and Chylous-Like Diseases in Children: Clinical Management”. Front Pediatr. 2019; 7: 258.
Tutor J.: “Chylothorax in infants and children”. Pediatrics. 2014; 133 (4): 722-733.
Romanowicz A., Sołtyszewski A., Haponiuk I., et al.: “Chłonkotok u pacjentów z wrodzonymi wadami serca w przebiegu leczenia kardiologicznego i kardiochirurgicznego”. Folia Cardiologica. 2018; 13 (4): 359-366.
Alhawri K., Mcmahon C., Alrih M. et al. “Atrioventricular septal defect and tetralogy of Fallot - A single tertiary center experience: A retrospective review”. Ann Pediatr Cardiol. 2019; 12(2): 103-109.
Alomari M., Lillis A., Kerr C. et al. “The Use of Non-ionic Contrast Agent for Lymphangiography and Embolization of the Thoracic Duct”. Cardiovasc Intervent Radiol. 2019; 42 (3): 481-483.
Kato M., Nomura K., Ko Y. et al.: “The use of indocyanine green lymphography for the treatment of postoperative chylothorax with lipiodol lymphangiography in a 2-year-old child”. J Pediatr Surg Case Rep. 2017; 23: 46–49.
Bang J., Kim S., Park C. et al.: “Anatomic variability of the thoracic duct in pediatric patients with complex congenital heart disease”. J Thorac Cardiovasc Surg. 2015; 150: 490-496.
Binsalamah Z., Ibarra C., John R. et al.: “Contemporary midterm outcomes in pediatric patients undergoing vascular ring repair”. Ann Thorac Surg. 2020; 109: 566-72.
Christofe N., Pessotti C., Paiva L., Jatene, I.: “Incidence and Treatment of Chylothorax in Children Undergoing Corrective Surgery for Congenital Heart Diseases”. Braz J Cardiovasc Surg. 2017; 32 (5): 390–393.
Czobor N., Roth G., Prodán Z. et al.: “Chylothorax after pediatric cardiac surgery complicates short-term but not long-term outcomes-a propensity matched analysis”. J Thorac Dis. 2017; 9 (8): 2466–2475.
El Midany A., Mostafa E., Mansour S. et al.: “Bilateral bidirectional Glenn: outcome of off-pump technique”. Interact CardioVasc Thorac Surg. 2017; 25: 745–9.
Fararjeh M., Najm H., Tamimi O.: “Spontaneous resolution of plastic bronchitis in a patient post hemi-Mustard/bidirectional Glenn atrial switch procedure in the double-switch operation for congenitally corrected transposition of great arteries after course of Augmentin”. J Saudi Heart Assoc. 2015; 27 (1): 54-56.
Guo Y., Chen J., Xu B. et al.: “Causes and manifestations of chylothorax in children in China: Experience from a children’s medical center, 2007-2017”. Pediatr Investig. 2018; 2: 8-14.
Iodice F., Testa G., Averardi M. et al.: “Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: Management and lessons learned”. Neuromuscul Disord. 2015; 25: 19-23.
Kakkar B., Agarwal M., Sehgal A., Govil N.: “Anesthetic considerations for video-assisted thoracoscopic surgery in a child with Glenn shunt for thoracic duct ligation and pleurodesis”. Saudi J. Anaesth. 2018; 12: 131-133.
Kumar T., Balduf K., Boston U., Knott-Craig C.: “Diaphragmatic fenestration for refractory chylothorax after congenital cardiac surgery in infants”. J Thorac Cardiovasc Surg.. 2017; 154: 2062-2068.
Lo Rito M., Al-Radi. O, Saedi A. et al.: “Chylothorax and pleural effusion in contemporary extracardiac fenestrated fontan completion”. J Thorac Cardiovasc Surg. 2018; 155: 2069-2077.
Majdalany B., Saad W., Chick J. et al.: “Pediatric lymphangiography, thoracic duct embolization and thoracic duct disruption: a single-institution experience in 11 children with chylothorax”. Pediatr Radiol. 2018; 48: 235-240.
Martin B., McBrien A., Marchak B. et al.: “Predicting Post-Fontan Length of Stay: The Limits of Measured Variables”. Pediatr Cardiol. 2019; 40: 1208-1216.
Nasser B., Mesned A., Moazamy Y., Kabbani M.: “Horner’s syndrome after paediatric cardiac surgery: Case report and review of the literature”. Cardiol Young. 2015; 25: 569-572.
Neumann L., Springer T., Nieschke K. et al.: “ChyloBEST: Chylothorax in Infants and Nutrition with Low-Fat Breast Milk”. Pediatr Cardiol. 2020; 41: 108-113.
Perry T., Bora K., Bakar A. et al..: “Non-surgical Risk Factors for the Development of Chylothorax in Children after Cardiac Surgery-Does Fluid Matter?”. Pediatr Cardiol. 2020; 41:194-200.
Sato N., Sugiura T,. Nagasaki R. et al.: “Effects of tolvaptan on congestive heart failure complicated with chylothorax in a neonate”. Pediatr Int. 2015; 57(5): 1020-1022.
Savla J., Itkin M., Rossano J., Dori Y.: “Post-Operative Chylothorax in Patients With Congenital Heart Disease”, J Am Coll Cardiol. 2017; 69 (19): 2410-2422.
Slater B., Rothenberg S.: “Thoracoscopic Thoracic Duct Ligation for Congenital and Acquired Disease”. J Laparoendosc Adv Surg Tech A. 2015; 25 (7): 605-607.
Talwar S., Das A., Choudhary S., Airan B.: “Diaphragmatic Fenestration for Resistant Pleural Effusions After Univentricular Palliation”. World J Pediatr Congenit Heart Surg. 2016; 7 (2): 146-151.
Weissler J., Cho E., Koltz P. et al.: “Lymphovenous Anastomosis for the Treatment of Chylothorax in Infants: A Novel Microsurgical Approach to a Devastating Problem”. Plast. Reconstr. Surg. 2018; 141 (6): 1502-1507.
Wu C., Wang Y., Pan Z. et al.: “Analysis of the etiology and treatment of chylothorax in 119 pediatric patients in a single clinical center”. J Pediatr Surg. 2019; 54 (7): 1293-1297.
Cho S., Kang S., Lee B., Choi S.: “Chylous Manifestations and Management of Gorham-Stout Syndrome”. Korean J Thorac Cardiovasc Surg. 2019; 52 (1): 44-46.
Dori Y., Smith C., Pinto E. et al.: “Severe Lymphatic Disorder Resolved With MEK Inhibition in a Patient With Noonan Syndrome and SOS1 Mutation”. Pediatrics. 2020; 146 (6): e20200167.
Ebrahimi-Fakhari D., Freiman E., Wojcik M. et al.: “Congenital Chylothorax as the Initial Presentation of PTPN11-Associated Noonan Syndrome”. J Pediatr. 2017; 185: 248-248.e1.
Jha V., Jha A.: “Unusual case of chylothorax with unilateral limb swelling”. BMJ Case Rep. 2020; 13: e230379.
Pham K., Balaguru D., Tammisetti V., et al.: “Multimodality lymphatic imaging of postoperative chylothorax in an infant with Noonan syndrome: a case report”. Eur J Med Res. 2020; 25 (1): 55.
Long A., Bunch K., Knight M. et al.: “BAPS-CASS. One-year outcomes of infants born with congenital diaphragmatic hernia: a national population cohort study”. Arch Dis Child Fetal Neonatal Ed. 2019; 104 (6): F643-F647.
Scottoni F., Fusaro F., Conforti A. et al.: “Pleurodesis with povidone-iodine for refractory chylothorax in newborns: Personal experience and literature review”. J Pediatr Surg. 2015; 50 (10): 1722-1725.
Upadhaya S., Joshi U., Gyawali S. et al.: “A late presenting left-sided congenital diaphragmatic hernia repair complicated by postoperative chylothorax: A case report”. Clin Case Rep. 2020; 9 (1): 350-354.
Zaki S., Krishnamurthy M., Malhotra A.: “Octreotide Use in Neonates: A Case Series”. Drugs R D. 2018; 18 (3): 191-198.
Heiwegen K., van Rooij I., van Heijst A. et al.: “Surgical Complications in Children with CDH: A Multivariate Analysis”. World J Surg. 2020; 44 (6): 2042-2048.
Toczewski K., Rygl M., Dzielendziak A. et al.:“Thoracoscopic repair of congenital isolated H-type tracheoesophageal fistula”. J Pediatr Surg. 2021; 56 (8): 1386-1388.
Silva J., Soares D., Leão M., Santos H.: “Mandibulofacial dysostosis with microcephaly: a syndrome to remember. BMJ Case Rep. 2019; 12 (8): e229831.
Muniz G., Hidalgo-Campos J., Valdivia-Tapia M. et al.: “Successful Management of Chylothorax With Etilefrine: Case Report in 2 Pediatric Patients”. Pediatrics. 2018; 141 (5): e20163309.
Luciano D., Mitchell J., Fraisse A. et al.: “Kommerell Diverticulum Should Be Removed in Children With Vascular Ring and Aberrant Left Subclavian Artery”. Ann Thorac Surg. 2015; 100 (6): 2293-2297.
Dokumcu Z., Uygun O., Turhan T. et al.: “Two-stage approach in the management of thoracic neuroenteric cyst with spinal extension: thoracoscopic excision following dorsal laminectomy”. Childs Nerv Syst. 2015; 31 (2): 185-189.
Cho S., Kim W., Choi E. et al.: “Surgical Results of Anomalous Origin of One Pulmonary Artery Branch from the Ascending Aorta”. Pediatr Cardiol. 2015; 36 (7): 1532-1538.
Goldstein S., Culbertson N., Garrett D. et al.: “Thymectomy for myasthenia gravis in children: a comparison of open and thoracoscopic approaches”. J Pediatr Surg. 2015; 50 (1): 92-97.
Goussard P., Gie R., Janson J., et al.: “Decompression of enlarged mediastinal lymph nodes due to mycobacterium tuberculosis causing severe airway obstruction in children”. Ann Thorac Surg. 2015; 99 (4): 1157-1163.
Baird C., Prabhu S., Buchmiller T.. et al.: “Direct Tracheobronchopexy and Posterior Descending Aortopexy for Severe Left Mainstem Bronchomalacia Associated With Congenital Pulmonary Airway Malformation and Left Circumflex Aortic Arch”. Ann Thorac Surg. 2016; 102 (1): e1-e4.
Hazer S., Aydogdu K., Incekara F. et al: “Pulmonary sequestrations: Issues related to diagnosis, possible complications, and comorbidities”. J Clin Anal Med. 2016; 7 (3).
El Madi A., Irtan S., Sauvat F. et al.: “Long-term results of the transmanubrial osteomuscular-sparing approach for pediatric tumors”. Pediatr Blood Cancer. 2017; 64 (10): 10.1002/pbc.26527.
White M., Bhat R., Greenough A.: “Neonatal Chylothoraces: A 10-Year Experience in a Tertiary Neonatal Referral Centre”. Case Rep Pediatr. 2019: 3903598. Published 2019 Mar 13.
Dewberry L., Wine T., Prager J., et al.: “Thoracoscopic Posterior Tracheopexy Is a Feasible and Effective Treatment for Tracheomalacia”. J Laparoendosc Adv Surg Tech A. 2019; 29 (10): 1228-1231.
Fumino S., Sakai K., Higashi M. et al.: “Advanced surgical strategy for giant mediastinal germ cell tumor in children”. J Pediatr Surg Case Rep. 2017; 27: 51-55.
Malleske D., Yoder B.: “Congenital chylothorax treated with oral sildenafil: a case report and review of the literature”. J Perinatol. 2015; 35 (5): 384-386.
Resch B., Freidl T., Reiterer F.: “Povidone-iodine pleurodesis for congenital chylothorax of the newborn”. Arch Dis Child Fetal Neonatal Ed. 2016; 101 (1): F87-F88.
McCormick A., Rosenberg S., Trier K., Balest A.: “A Case of a Central Conducting Lymphatic Anomaly Responsive to Sirolimus”. Pediatrics. 2016; 137 (1). pp. e20152694.
Bülow L., Lissewski C., Bressel R., et al.: “Hydrops, fetal pleural effusions and chylothorax in three patients with CBL mutations”. Am J Med Genet A. 2015; 167A (2): 394-399.
Pinto E., Dori Y., Smith C. et al.: “Neonatal lymphatic flow disorders: impact of lymphatic imaging and interventions on outcomes”. J Perinatol. 2021; 41: 494–501.
Tanahashi Y., Ozeki M., Kawada H. et al.: “Direct-Puncture Lymphatic Embolization in the Prone Position for Chylothorax Caused by Lymphatic Anomaly”. J Vasc Interv Radiol. 2020; 31 (5): 849-852.e1.
Janssens P., Dekeuleneer V., Van Damme A. et al.: “Angiosarcoma arising from congenital primary lymphedema”. Pediatr Dermatol. 2018; 35 (6): e382-e388.
Aukema S., Ten Brinke G., Timens W. et al.: “A homozygous variant in growth and differentiation factor 2 (GDF2) may cause lymphatic dysplasia with hydrothorax and nonimmune hydrops fetalis”. Am J Med Genet A. 2020; 182 (9): 2152-2160.
Chandran S., Agarwal A., Llanora G., Chua M.: “Necrotising enterocolitis in a newborn infant treated with octreotide for chylous effusion: is octreotide safe?”. BMJ Case Rep. 2020; 13 (2): e232062.
Healy H., Gipson K., Hay S. et al.: “Management and outcomes of congenital chylothorax in the neonatal intensive care unit: A case series”. Pediatr Investig. 2017; 1 (1): 21-25.
Peng Y., Zhong W., He Q. et al.: “Treatment of fetal congenital chylothorax: Report of eight cases at a mainland Chinese medical center”. Taiwan J Obstet Gynecol. 2017; 56 (6): 867-869.
Hua Q., Lin Z., Hu X., Zhao Q.: “Treatment of persistent congenital chylothorax with intrapleural injection of sapylin in infants”. Pak J Med Sci. 2016; 32 (5): 1305-1308.
Lin C., Lin W., Chang J.: “Presentations and management of different causes of chylothorax in children: one medical center's experience”. Biomedicine (Taipei). 2017; 7 (1): 5.
Guo Y., Chen J., Xu B. et al.: “Causes and manifestations of chylothorax in children in China: Experience from a children's medical center, 2007-2017”. Pediatr Investig. 2018; 2 (1): 8-14.
Ramaroli D., Cavarzere P., Cheli M. et al.: “A Child with Early-Onset Gorham-Stout Disease Complicated by Chylothorax: Near-Complete Regression of Bone Lesions with Interferon and Bisphosphonate Treatment”. Horm Res Paediatr. 2019; 91 (6): 406-410.
Hangul M., Kose M., Ozcan A., Unal E.: “Propranolol treatment for chylothorax due to diffuse lymphangiomatosis”. Pediatr Blood Cancer. 2019; 66 (5): e27592.
Kumar T., Subramanian S., Sathanandam S. et al.: “Superior Vena Cava Reconstruction for Treatment of Chylothorax Resulting From Thrombosis of Superior Vena Cava in Young Infants”. Ann Thorac Surg. 2015; 100 (4): 1432-1436.
Rathore V., Bhattacharya D., Pandey J. et al.: “Chylothorax in a Child with Nephrotic Syndrome”. Indian J Nephrol. 2020; 30 (1): 32-34.
Totadri S., Trehan A., Bhattacharya A. et al.: “Chylothorax in children with cancer: A milky predicament”. Indian J Cancer. 2017; 54 (4): 691-694.
Rodrigues A., Romaneli M., Ramos C. et al.: “Bilateral spontaneous chylothorax after severe vomiting in children”. Rev Paul Pediatr. 2016; 34 (4): 518-521.
Wronowski M., Kotowska M., Krenke K., Albrecht P.: “Chylothorax and necrotizing pneumonia as complications of vomiting and cough induced by placement of a gastric tube for enteral nutrition in a 8-year old boy with Crohn's disease”. Pediatr Pol. 2017; 92 (4): 450-452.
Jahn H., Frost J. H., van As A.: “Traumatic chylothorax in a young child: Case report and management”. Afr J Emerg Med. 2017; 7 (2): 84-86.
Kakaje A., Mujahed R., Hamdan O., Hakim J.: “A large epithelioid angiomyolipoma of the kidney in a very young child with idiopathic chylothorax: A diagnostic dilemma”. Urol Case Rep. 2019; 28: 101035.
Long W., Cai B., Deng J. et al.: “Chemical pleurodesis and somatostatin in treating spontaneous chylothorax in pediatric patients: a retrospective analysis and review of the literature”. Transl Pediatr. 2020; 9 (4): 551-560.
Tan R., Witlox R., Hilhorst-Hofstee Y. et al.: “Clinical and molecular characterization of an infant with a tandem duplication and deletion of 19p13”. Am J Med Genet A. 2015; 167A (8): 1884-1889.
Iio K., Soneda K., Shimotakahara A.: “Effective method of evaluating infantile chylothorax”. Pediatr Int. 2019; 61 (2): 203-205.
Briceno-Medina M., Perez M., Zhang J. et al.: “A Case of Bilateral Spontaneous Chylothorax with Respiratory Syncytial Virus Bronchiolitis”. Case Rep Pediatr. 2019; 2019: 2853632.
Soto-Martinez M., Massie J.: “Chylothorax: diagnosis and management in children”. Paediatr Respir Rev. 2009; 10 (4): 199-207.
Alvarez J., Kalache K., Grauel E.: “Management of spontaneous congenital chylothorax: oral medium-chain triglycerides versus total parenteral nutrition” Am J Perinatol. 1999; 16 (8): 415-420.
DiLauro S., Russell J., McCrindle B. et al: “Growth of cardiac infants with post-surgical chylothorax can be supported using modified fat breast milk with proactive nutrient-enrichment and advancement feeding protocols; an open-label trial”. Clin Nutr ESPEN. 2020; 38: 19-27.
Carter S., van de Hoef D., Temple M. et al.: “Plastic bronchitis: a rare complication of long-term haemodialysis catheter placement in a child”. Pediatr Nephrol. 2017; 32 (9): 1635-1638.
Yin R., Zhang R., Wang J. et al.“ Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax”. Medicine (Baltimore). 2017; 96 (29): e7594
Tomobe Y., Mizuguchi U., Shimotakahara A. et al.: “Combination Therapy with Etilefrine and Pleurodesis for Refractory Congenital Chylothorax”. Biomed Hub. 2020; 5 (3): 907-911.
Ayuk A., Gray D., Vanker A., Zampoli M.: “Tuberculosis in children presenting with chylothorax - Report of two cases and review of the literature”. Respir Med Case Rep. 2019; 27: 100848.
Rössler J., Saueressig U., Kayser G. et al.: “Personalized Therapy for Generalized Lymphatic Anomaly/Gorham-Stout Disease With a Combination of Sunitinib and Taxol”. J Pediatr Hematol Oncol. 2015; 37 (8): e481-e485.
Wu Y., Li J., Wu C. et al.: “Diagnosis and Surgical Repair for Coarctation of the Aorta With Intracardiac Defects: A Single Center Experience Based on 93 Infants”. Front Pediatr. 2020; 8: 49.
Thatcher A., Yu J., Kuo K.: “High-volume bilateral chylothorax presenting with hypoxemia and shock in a pediatric patient following tracheostomy revision: a case report”. J Med Case Reports. 2015; 9: 235.
Law M., McMahon W., Hock K. et al.: “Balloon Angioplasty for the Treatment of Left Innominate Vein Obstruction Related Chylothorax after Congenital Heart Surgery”. Congenit Heart Dis. 2015; 10 (4): E155-E163.
Long W., Cai B., Liu Y. et al.: “Povidone-iodine chemical pleurodesis in treating spontaneous chylothorax in pediatric patients”. Ann Palliat Med. 2020; 9 (3): 1004-1012.
Agaram N.: “40 - Liver Pathology in Systemic Diseases and Diseases of Other Organs” in Practical Hepatic Pathology: A Diagnostic Approach, Saxena R., Ed. Saint Louis: Saunders W.B. 2011; 567-574.
Spiwak E., Wiesenauer C., Panigrahi A., Raj A.: “Use of Pleuroperitoneal Shunt in Chylothorax Related to Central Line Associated Thrombosis in Sickle Cell Disease”. Children (Basel). 2018; 5 (1): 7.
Kato M., Nomura K., Ko Y. et al.: “The use of indocyanine green lymphography for the treatment of postoperative chylothorax with lipiodol lymphangiography in a 2-year-old child”. J Pediatr Surg Case Rep. 2017; 23: 46-49.
Courtney M., Ayyagari R.: “Idiopathic chylopericardium treated by percutaneous thoracic duct embolization after failed surgical thoracic duct ligation”. Pediatr Radiol. 2015; 45 (6): 927-930.
Irtan S., Brisse H., Minard-Colin V. et al.: “Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and image-defined risk factors”. Pediatr Blood Cancer. 2015; 62 (2): 257-261.
Guedes F., Brown R., Torrão-Junior F. et al: “Pediatric peripheral nerve tumors: clinical and surgical aspects”. Childs Nerv Syst. 2019; 35 (12): 2289-2297.
Mehta K., Shinde S., Rego S., Shet A.: “Hepatitis A Associated with Chylothorax: An Uncommon Presentation of a Common Infection”. J Trop Pediatr. 2015; 61 (6): 468-473.
Ichikawa Y., Sato A., Sato K. et al.: “Chylothorax associated with child abuse”. Pediatr Int. 2015; 57 (6): 1202-1204.
Cook S., Ali S., Pracher F., Gautam A.: “Chylothorax complicating central venous access and thoracocentesis in an infant with parapneumonic empyema”. J Paediatr Child Health. 2021; 57 (8): 1331-1333.
Fujino S., Maruyama H., Tsukamoto K. et al.: “Chylothorax Associated with Congenital Complete Atrioventricular Block”. AJP Rep. 2020; 10 (4): e403-e407.
Ellender C., Williams T., Gooi J. et al.: “Management of refractory chylothorax in pulmonary lymphangioleiomyomatosis”. Respirol Case Rep. 2015; 3 (2): 72-74.
Stringel G., Teixeira J.: “Thoracoscopic ligation of the thoracic duct”. JSLS. 2000; 4 (3): 239-242.
Perry T., Bora K., Bakar A. et al.: “Non-surgical Risk Factors for the Development of Chylothorax in Children after Cardiac Surgery-Does Fluid Matter?” Pediatr Cardiol. 2020; 41 (1): 194-200.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Kinga Knop, Anna Kochanowska, Zuzanna Piasecka, Karolina Kosieradzka, Małgorzata Drozd, Anna Bodajko-Grochowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 433
Number of citations: 0
